References
Rutanen. Insulin-like growth factors in obstetrics. Curr Opin Obstet Gynecol (2000) 12:163-168 Guibourdenche et. al. Rapid detection of insulin-like growth factor-binding protein-1 and foetal fibronectin in cervico-vaginal secretions to diagnose premature membrane rupture. Ann Clin Biochem (1999) 36: 388-390. Kubota and Takeuchi. Evaluation of Insulin-like Growth Factor Binding Protein-1 as diagnostic tool for rupture of membranes. J Obstet Gynaecol Res (1998) 24:411-417. Darj and Lyrenas. Insulin-like growth factor binding protein-1, a quick way to detect amniotic fluid. Acta Obstet Gynecol Scand (1998) 77: 295-297. Jain and Morris. A clinical study to evaluate the usefulness of the MAST test in diagnosing pre-labour rupture of membranes. J Obstet Gynecol (1998) 18:33-36. Paternoster et. al. Insulin-like growth factor protein test (IGFBP-1) in predicting preterm delivery. Labor and delivery. The Proceedings of the 2nd World Congress on Labor and Delivery. May 1997, Rome Italy. Ragosch et. al. Insulin like growth factor binding protein 1 (IGFBP-1) und fetales Fibronectin in der Diagnostik eines vorzeitigen Blasensprunges. Geburts u. Frauenheilk (1996) 56:1-6 Rutanen et. al. Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clinica Chimica Acta (1996) 253:91-101. Rutanen et. al. Measurement of insulin-like growth factor binding protein-1 in cervical/vaginal secretions: comparison with the ROM-check Membrane Immunoassay in the diagnosis of ruptured fetal membranes. Clinica Chimica Acta (1993) 214:73-81. Wathen et. al. Levels of insulin-like growth factor-binding protein-1 increase rapidly in amniotic fluid from 11 to 16 weeks of pregnancy. J Endocrinol (1993) 137:R1-R |